Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Michielin O"'
Autor:
de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Mora AR; Competence Center of Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Zippelius A; Department of Biomedicine, Division of Medical Oncology, University Hospital and University of Basel, Basel, Switzerland., van der Veldt A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Gerard CL; Precision Oncology Center, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Läubli H; Department of Biomedicine, Division of Medical Oncology, University Hospital and University of Basel, Basel, Switzerland., Michielin O; Department of Medical Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., von Moos R; Department of Oncology/Hematology, Cantonal Hospital Graubünden, Chur, Switzerland., Joerger M; Department of Oncology/Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Levesque MP; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Aeppli S; Department of Oncology/Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Mangana J; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Mangas C; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland., Trost N; Department of Molecular Diagnostics and Research, Blood Transfusion Service Zurich, Swiss Red Cross, Schlieren, Switzerland., Meyer S; Department of Molecular Diagnostics and Research, Blood Transfusion Service Zurich, Swiss Red Cross, Schlieren, Switzerland., Parvex SL; Pathology Institute, Ente Ospedaliero Cantonale (EOC), Locarno, Switzerland., Mathijssen R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Metaxas Y; Department of Medical Oncology, Cantonal Hospital Muensterlingen, Muensterlingen, Switzerland.
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2024 Jun 01; Vol. 47 (5), pp. 190-194. Date of Electronic Publication: 2024 Feb 06.
Autor:
Taylor AM; Melanoma Institute Australia, The University of Sydney, Australia., McKeown J; Melanoma Institute Australia, The University of Sydney, Australia., Dimitriou F; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland., Jacques SK; Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, Australia., Zimmer L; Department of Dermatology, University Hospital Essen, Essen, Germany., Allayous C; Université Paris Cite,AP-HP Dermato-oncology, Cancer institute APHP.nord Paris cité, INSERM U976, Saint Louis Hospital, Paris, France., Yeoh HL; Alfred Health, Melbourne, Australia., Haydon A; Alfred Health, Melbourne, Australia., Ressler JM; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Galea C; Melanoma Institute Australia, The University of Sydney, Australia., Woodford R; Melanoma Institute Australia, The University of Sydney, Australia., Kahler K; University Hospital (UKSH), Campus Kiel, Department of Dermatology, Kiel, Germany., Hauschild A; University Hospital (UKSH), Campus Kiel, Department of Dermatology, Kiel, Germany., Festino L; Melanoma. Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy., Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Schwarze JK; Department of Medical Oncology, Brussels, Belgium., Neyns B; Department of Medical Oncology, Brussels, Belgium., Wicky A; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Michielin O; Precision Oncology Center, Lausanne University Hospital, Switzerland., Placzke J; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Johnson DB; Vanderbilt University Medical Center, Nashville, USA., Lebbe C; Université Paris Cite,AP-HP Dermato-oncology, Cancer institute APHP.nord Paris cité, INSERM U976, Saint Louis Hospital, Paris, France., Dummer R; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland., Ascierto PA; Melanoma. Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy., Lo S; Melanoma Institute Australia, The University of Sydney, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., Carlino MS; Melanoma Institute Australia, The University of Sydney, Australia; Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia. Electronic address: alexander.menzies@sydney.edu.au.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113561. Date of Electronic Publication: 2024 Jan 20.
Autor:
Jacques SK; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, Australia., McKeown J; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Grover P; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Johnson DB; Vanderbilt University Medical Centre, Nashville, TN, USA., Zaremba A; Department of Dermatology, Venereology and Allergology, University Hospital Essen, Essen, Germany., Dimitriou F; Department of Dermatology, University Hospital of Zurich and Faculty of Medicine, University of Zürich, Zurich, Switzerland., Weiser R; MD Anderson Cancer Center, Houston, TX, USA., Farid M; National Cancer Centre, Singapore., Namikawa K; Department of Dermatologic Oncology, National Cancer Center, Tokyo, Japan., Sullivan RJ; Massachusetts General Hospital, Harvard University, Boston, MA, USA., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Lebbe C; Université Paris Cite,AP-HP Dermato-oncology, Cancer institute APHP.nord Paris cité, INSERM U976, Saint Louis Hospital, Paris, France., Hamid O; The Angeles Clinic, A Cedars-Sinai Affiliate, Los Angeles, CA, USA., Zager JS; Department of Cutaneous Oncology, Moffit Cancer Center, Tampa, FL, USA., Michielin O; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Neyns B; Universitair Ziekenhuis Brussel, Brussels, Belgium., Nakamura Y; Department of Skin Oncology/Dermatology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan., Robert C; Institute Gustave Roussy and Paris Saclay University, Villejuif Cedex, France., Mehnert J; NYU Langone, New York City, NY, USA., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Bhave P; Sir Peter MacCallum Cancer Centre Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Park B; Vanderbilt University Medical Centre, Nashville, TN, USA., Zimmer L; Department of Dermatology, Venereology and Allergology, University Hospital Essen, Essen, Germany., Mangana J; Department of Dermatology, University Hospital of Zurich and Faculty of Medicine, University of Zürich, Zurich, Switzerland., Mooradian M; Massachusetts General Hospital, Harvard University, Boston, MA, USA., Placzke J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Allayous C; Université Paris Cite,AP-HP Dermato-oncology, Cancer institute APHP.nord Paris cité, INSERM U976, Saint Louis Hospital, Paris, France., Glitza Oliva IC; MD Anderson Cancer Center, Houston, TX, USA., Mehmi I; The Angeles Clinic, A Cedars-Sinai Affiliate, Los Angeles, CA, USA., Depalo D; Department of Cutaneous Oncology, Moffit Cancer Center, Tampa, FL, USA., Wicky A; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Schwarze JK; Universitair Ziekenhuis Brussel, Brussels, Belgium., Roy S; Institute Gustave Roussy and Paris Saclay University, Villejuif Cedex, France., Boatwright C; NYU Langone, New York City, NY, USA., Vanella V; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia., Carlino MS; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. Electronic address: matteo.carlino@sydney.edu.au.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113563. Date of Electronic Publication: 2024 Jan 22.
Autor:
Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Ghisoni E; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Chiffelle J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Orcurto A; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Dagher J; Unit of Translational Oncopathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland., Fahr N; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland., Benedetti F; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland., Crespo I; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland., Grimm AJ; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland., Morotti M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland., Zimmermann S; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Duran R; Department of Radiology and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland., Imbimbo M; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., de Olza MO; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Navarro B; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Homicsko K; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Labes D; Flow Cytometry Facility, Department of Formation and Research, University of Lausanne, Epalinges, Switzerland., Tsourti Z; Scientific Research Consulting Hellas, Athens, Greece., Andriakopoulou C; Scientific Research Consulting Hellas, Athens, Greece., Herrera F; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Service of Radiation Oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Pétremand R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Berthod G; Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Kraemer AI; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Huber F; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Thevenet J; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Department of Oncology, Center of Experimental Therapeutics, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Schaefer N; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland., Prior JO; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland., Matter M; Department of Visceral Surgery, Lausanne University Hospital, and University of Lausanne, Lausannne, Switzerland., Aedo V; Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dromain C; Department of Radiology and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland., Corria-Osorio J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Tissot S; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Department of Oncology, Center of Experimental Therapeutics, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Department of Oncology, Center of Experimental Therapeutics, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Gottardo R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Biomedical Data Science Center and Swiss Institute of Bioinformatics, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Pittet M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Sempoux C; Unit of Translational Oncopathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland., Michielin O; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dafni U; Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece., Trueb L; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Laniti DD; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
Publikováno v:
Science immunology [Sci Immunol] 2024 Feb 02; Vol. 9 (92), pp. eadg7995. Date of Electronic Publication: 2024 Feb 02.
Autor:
Hepner A; Melanoma Institute Australia, The University of Sydney, NSW, Australia; Instituto do Cancer do Estado de Sao Paulo, SP, Brazil., Versluis JM; Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands., Wallace R; Sir Peter MacCallum Cancer Centre Department of Oncology, The University of Melbourne, Melbourne, Australia., Allayous C; Université Paris Cite, Dermato-Oncology AP-HP Hôpital Saint Louis, INSERM U976, F-75010 Paris, France., Brown LJ; Crown Princess Mary Cancer Centre Westmead and Blacktown Hospitals, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia., Trojaniello C; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Gerard CL; Precision Oncology Center Oncology department, Lausanne University Hospital CHUV, Lausanne, Switzerland., Jansen YJ; Department of Thoracic Surgery, University Hospitals Leuven, Leuven 3000, Belgium., Bhave P; Sir Peter MacCallum Cancer Centre Department of Oncology, The University of Melbourne, Melbourne, Australia; Department of Medical Oncology, Alfred Health, Melbourne, Australia., Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Haydon A; Department of Medical Oncology, Alfred Health, Melbourne, Australia; Monash University, Melbourne, Australia., Michielin O; Precision Oncology Center Oncology department, Lausanne University Hospital CHUV, Lausanne, Switzerland., Mangana J; University Hospital Zürich, Zürich, Switzerland., Klein O; Olivia Newton-John Cancer Centre and Austin Health, Melbourne, Australia., Shoushtari AN; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA., Warner AB; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., McQuade JL; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carlino MS; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zimmer L; Department of Dermatology, University Hospital Essen, Essen, Germany., Lebbe C; Université Paris Cite, Dermato-Oncology AP-HP Hôpital Saint Louis, INSERM U976, F-75010 Paris, France., Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville TN, USA., Sandhu S; Sir Peter MacCallum Cancer Centre Department of Oncology, The University of Melbourne, Melbourne, Australia; University of Melbourne, Melbourne, Australia., Atkinson V; University of Queensland and Princess Alexandra and Greenslopes Private Hospital, Brisbane, Australia., Blank CU; Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands; Leiden University Medical Center (LUMC), Leiden, the Netherlands., Lo SN; Melanoma Institute Australia, The University of Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, NSW, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, NSW, Australia. Electronic address: alexander.menzies@sydney.edu.au.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Jan; Vol. 196, pp. 113441. Date of Electronic Publication: 2023 Nov 20.
Autor:
Anchisi S; Oncology, Centre Hospitalier du Valais Romand, Sion, Switzerland., Wolfer A; Swiss Agency for Therapeutic Products, SwissMedic, Bern, Switzerland., Bisig B; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland., Missiglia E; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland., Tiab A; Service of Histocytopathology, Institut Central des Hôpitaux Valaisans, Sion, Switzerland., Kamel EM; Nuclear Medicine, Centre Hospitalier du Valais Romand, Sion, Switzerland., Michielin O; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Coukos G; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Homicsko K; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.
Publikováno v:
Cancer biology & therapy [Cancer Biol Ther] 2023 Dec 31; Vol. 24 (1), pp. 2193116.
Autor:
Courlet P; Precision Oncology Center, Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Abler D; Precision Oncology Center, Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Institute of Informatics, School of Management, University of Applied Sciences Western Switzerland (HES-SO), Sierre, Switzerland., Guidi M; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Girard P; Merck Institute of Pharmacometrics, Ares Trading S.A. (an affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland., Amato F; Swiss Data Science Centre, École Polytechnique Fédérale de Lausanne (EPFL) and Eidgenössische Technische Hochschule Zurich (ETH), Zurich, Switzerland., Vietti Violi N; Department of Radiology and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Dietz M; Nuclear Medicine and Molecular Imaging Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Guignard N; Department of Radiology and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Wicky A; Precision Oncology Center, Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Latifyan S; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., De Micheli R; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Jreige M; Nuclear Medicine and Molecular Imaging Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Dromain C; Department of Radiology and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Csajka C; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Geneva, Switzerland.; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland., Prior JO; Nuclear Medicine and Molecular Imaging Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Venkatakrishnan K; EMD Serono Research and Development Institute, Inc, Billerica, Massachusetts, USA., Michielin O; Precision Oncology Center, Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Cuendet MA; Precision Oncology Center, Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA., Terranova N; Merck Institute of Pharmacometrics, Ares Trading S.A. (an affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Aug; Vol. 12 (8), pp. 1170-1181. Date of Electronic Publication: 2023 Jun 16.
Autor:
Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy. paolo.ascierto@gmail.com., Agarwala SS; Temple University School of Medicine, Philadelphia, PA, USA., Warner AB; Stanford University School of Medicine, Stanford, CA, USA., Ernstoff MS; ImmunoOncology Branch (IOB), Developmental Therapeutics Program, Cancer Therapy and Diagnosis Division, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., Fox BA; Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Gajewski TF; Department of Pathology and Department of Medicine (Section of Hematology/Oncology), University of Chicago, Chicago, IL, USA., Galon J; INSERM, Laboratory of Integrative Cancer Immunology, 75006, Paris, France.; Centre de Recherche Des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.; Equipe Labellisée Ligue Contre le Cancer, Paris, France., Garbe C; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Gastman BR; Department of Surgery, School of Medicine, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kalinski P; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Krogsgaard M; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA., Leidner RS; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Lo RS; Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Menzies AM; Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia., Michielin O; Department of Oncology, Geneva University Hospital, Geneva, Switzerland., Poulikakos PI; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Weber JS; Laura and Isaac Perlmutter Cancer Center, a NCI-Funded Comprehensive Cancer Center, NYU School of Medicine, New York, NY, USA., Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori 'Fondazione Pascale' IRCCS, Naples, Italy., Osman I; Rudolf L, Baer, New York University Langone Medical Center, New York, NY, USA., Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Thurin M; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institute of Health (NIH), Bethesda, MD, USA.
Publikováno v:
Journal of translational medicine [J Transl Med] 2023 Jul 28; Vol. 21 (1), pp. 508. Date of Electronic Publication: 2023 Jul 28.
Autor:
Schmidt J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Chiffelle J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Perez MAS; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Magnin M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Bobisse S; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Arnaud M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Genolet R; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Cesbron J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Barras D; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Navarro Rodrigo B; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Benedetti F; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Michel A; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Queiroz L; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Baumgaertner P; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Guillaume P; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Hebeisen M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland., Michielin O; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Nguyen-Ngoc T; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland., Huber F; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Irving M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland., Tissot-Renaud S; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Stevenson BJ; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Rusakiewicz S; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Rufer N; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland., Gfeller D; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Speiser DE; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland., Zoete V; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Coukos G; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland. Alexandre.Harari@chuv.ch.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland. Alexandre.Harari@chuv.ch.
Publikováno v:
Nature communications [Nat Commun] 2023 Jun 06; Vol. 14 (1), pp. 3188. Date of Electronic Publication: 2023 Jun 06.
Autor:
Garbe C; Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. claus.garbe@med.uni-tuebingen.de., Dummer R; Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland. Reinhard.Dummer@usz.ch.; Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland. Reinhard.Dummer@usz.ch., Amaral T; Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ascierto PA; Department of Skin Cancer, Cancer Immunotherapy and Development Therapeutics, Instituto Nazionale Tumouri IRCCS Fondazione G. Pascale, Napoli, Italy., Burton EM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dreno B; Nantes University, Nantes, France., Eggermont AMM; Faculty of Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.; Comprehensive Cancer Centre Munich of the Technical University Munich and the Ludwig Maximilians University, Munich, Germany., Hauschild A; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany., Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Kaufmann R; Department of Dermatology, Venerology and Allergology, Frankfurt University Hospital, Frankfurt, Germany., Lebbe C; Université Paris Cite, AP-HP Department of Dermatology, Hôpital Saint-Louis Paris, Paris, France., Mandala M; Department of Surgery and Medicine, Unit of Medical Oncology, University of Perugia, Perugia, Italy., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Faculty of Medicine & Health, The University of Sydney, Sydney, NSW, Australia., Moreno D; Medical & Surgical Dermatology Service, Hospital Universitario Virgen Macarena, Sevilla, Spain., Michielin O; Department of Medical Oncology, Lausanne University Hospital, Lausanne, Switzerland., Nathan P; Mount Vernon Cancer Centre, Northwood, UK., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Robert C; Department of Medical Oncology, Gustave Roussy and Paris-Saclay University, Villejuif, France., Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Heidelberg Partner Site Essen, Essen, Germany., Lorigan PC; University of Manchester, Manchester, UK., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Faculty of Medicine & Health, The University of Sydney, Sydney, NSW, Australia., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., van de Wiel BA; Department of Pathology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Blank C; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.; Leiden University Medical Centre (LUMC), Leiden, The Netherlands., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Faculty of Medicine & Health, The University of Sydney, Sydney, NSW, Australia.
Publikováno v:
Nature medicine [Nat Med] 2023 Jun; Vol. 29 (6), pp. 1310-1312.